MGK

Michael G. King Jr.

#1408 out of 1699 analysts
Rodman & Renshaw
Automatically Tracked
Tracking: 0 Updated: Jun 18 at 06:51 PM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
-15.95%
Gain -2.83%
Monthly
-15.95%
Yearly
-15.95%
Drawdown
15.96%
$84,049.97
Equity
Holdings
$84,049.97
Cash
$0
Investment
$94,000
-$15,950.03
Profit -$2,444.59
Realized
-$6,000
Unrealized
-$9,950.03
Dividends
$0
$0
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-2.83%
Profit
-$2,444.59
Win %
50%
This Week
Compared To Last Week
Gain
-6.95%
Profit
-$6,272.47
Win %
50%
This Month
Compared to last month
Gain
-15.95%
Profit
-$15,950.03
Win %
33%
This Year
Compared to last year
Gain
-15.95%
Profit
-$15,950.03
Win %
33%
No Data
Kyntra Bio, Inc. logo
KYNB Kyntra Bio, Inc.
-2.03%
-$920.78
Bolt Biotherapeutics Inc. logo
BOLT Bolt Biotherapeutics Inc.
-1.43%
-$571.43
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
3
Longs Won
1/3 33%
Profit Factor
0.03
Profitability
Shorts Won
0/0 0%
Standard Deviation
$5,868.57
Average Win
$526.16
Best Trade
(Jun 15) $3,334.53
Sharpe Ratio
-10.44
Average Loss
-$8,238.1
Worst Trade
(Jun 18) -$10,476.19
Z-Score
0.35 (27.63%)
Commissions
$0
Avg. Trade Length
1w 6d
Expectancy
-$5,316.68
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss - - - - - - - - - -
Consecutive Losing Trades 10 9 8 7 6 5 4 3 2 1
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV